Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MAb3E10: Began a Phase I study

MedClone Inc., Los

Read the full 38 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE